Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1977 1
1979 2
1981 1
1982 3
1983 1
1984 2
1985 4
1986 1
1987 1
1988 3
1990 2
1991 2
1992 1
1993 1
1994 5
1995 2
1996 8
1997 7
1998 4
1999 1
2000 5
2001 7
2002 8
2003 4
2004 7
2005 7
2006 5
2007 4
2008 3
2009 5
2010 9
2011 7
2012 5
2013 8
2014 6
2015 10
2016 11
2017 10
2018 10
2019 6
2020 16
2021 12
2022 15
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
Yaku A, Inagaki T, Asano R, Okazawa M, Mori H, Sato A, Hia F, Masaki T, Manabe Y, Ishibashi T, Vandenbon A, Nakatsuka Y, Akaki K, Yoshinaga M, Uehata T, Mino T, Morita S, Ishibashi-Ueda H, Morinobu A, Tsujimura T, Ogo T, Nakaoka Y, Takeuchi O. Yaku A, et al. Among authors: nakaoka y. Circulation. 2022 Sep 27;146(13):1006-1022. doi: 10.1161/CIRCULATIONAHA.122.059435. Epub 2022 Aug 23. Circulation. 2022. PMID: 35997026
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension.
Masaki T, Okazawa M, Asano R, Inagaki T, Ishibashi T, Yamagishi A, Umeki-Mizushima S, Nishimura M, Manabe Y, Ishibashi-Ueda H, Shirai M, Tsuchimochi H, Pearson JT, Kumanogoh A, Sakata Y, Ogo T, Kishimoto T, Nakaoka Y. Masaki T, et al. Among authors: nakaoka y. Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2023899118. doi: 10.1073/pnas.2023899118. Proc Natl Acad Sci U S A. 2021. PMID: 33836606 Free PMC article.
Sperm and Oocyte Chromosomal Abnormalities.
Samura O, Nakaoka Y, Miharu N. Samura O, et al. Among authors: nakaoka y. Biomolecules. 2023 Jun 17;13(6):1010. doi: 10.3390/biom13061010. Biomolecules. 2023. PMID: 37371589 Free PMC article. Review.
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N. Nakaoka Y, et al. Ann Rheum Dis. 2018 Mar;77(3):348-354. doi: 10.1136/annrheumdis-2017-211878. Epub 2017 Nov 30. Ann Rheum Dis. 2018. PMID: 29191819 Free PMC article. Clinical Trial.
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis.
Manabe Y, Ishibashi T, Asano R, Tonomura S, Maeda Y, Motooka D, Ueda J, Yanagawa M, Edamoto-Taira Y, Chikaishi-Kirino T, Masaki T, Inagaki T, Nakamura S, Katada Y, Okazawa M, Narazaki M, Ogo T, Kumanogoh A, Nakaoka Y. Manabe Y, et al. Among authors: nakaoka y. Arthritis Res Ther. 2023 Mar 24;25(1):46. doi: 10.1186/s13075-023-03031-9. Arthritis Res Ther. 2023. PMID: 36964623 Free PMC article.
Biomarkers for Takayasu arteritis: Which is the most promising?
Ishibashi T, Nakaoka Y. Ishibashi T, et al. Among authors: nakaoka y. Int J Cardiol. 2023 Jan 15;371:418-419. doi: 10.1016/j.ijcard.2022.09.048. Epub 2022 Sep 27. Int J Cardiol. 2023. PMID: 36174823 No abstract available.
235 results